Home › NDC Lookup › RxCUI directory › RxCUI 1797867

Azelastine hydrochloride 0.137 MG/ACTUAT Metered Dose Nasal Spray — RxCUI 1797867

RxNorm drug concept · Semantic clinical drug
RxCUI 1797867 Semantic clinical drug · SCD ● Current RxNorm concept 12 FDA products 12 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1797867
Official nameAzelastine hydrochloride 0.137 MG/ACTUAT Metered Dose Nasal Spray
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asazelastine HCl 137 MCG/ACTUAT Metered Dose Nasal Spray
FDA products mapped12
Package NDCs mapped12
Reported Medicaid activity (SDUD)1,133,133 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Azelastine Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • They treat itchy eyes caused by allergic conjunctivitis, which is an allergic reaction affecting the eye. They are not described for other eye problems.
  • Put one drop in each affected eye, usually twice a day. Follow your prescriber's directions and your label. They are for the eyes only, so never swallow them or inject them.
  • They might. About 30% of people notice brief burning or stinging. It is usually mild and short-lived.
  • A bitter taste was reported by about 10% of people using the drops. It is usually mild. Headache is also fairly common, at about 15%.
📖 Read our full Azelastine Ophthalmic guide →

🕸️ Concept Web — How Azelastine hydrochloride 0.137 MG/ACTUAT Metered... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Azelastine hydrochloride 0.137 MG/ACTUAT Metered Dose Nasal Spray RxCUI 1797867

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Azelastine 18603
    • Azelastine hydrochloride 235824
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Azelastine Metered Dose Nasal Spray 1797866
    • Azelastine hydrochloride Metered Dose Nasal Spray 2648471
    • Azelastine Inhalant Product 1158841
    • Azelastine Nasal Product 1158842
    • Azelastine hydrochloride Inhalant Product 2661317
    • Azelastine hydrochloride Nasal Product 2659109
    • Metered Dose Nasal Spray 1797831
    • Inhalant Product 1151123
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Azelastine hydrochloride 0.137 MG/ACTUAT 860795

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Azelastine hydrochloride 0.137 MG/ACTUAT SCDC · 860795
  • Azelastine Metered Dose Nasal Spray SCDF · 1797866
  • Azelastine hydrochloride Metered Dose Nasal Spray SCDFP · 2648471
  • Azelastine Inhalant Product SCDG · 1158841
  • Azelastine Nasal Product SCDG · 1158842
  • Azelastine hydrochloride Inhalant Product SCDGP · 2661317
  • Azelastine hydrochloride Nasal Product SCDGP · 2659109

📦 FDA Products & Package NDCs

12 products · 12 package NDCs
12 package NDCs map to RxCUI 1797867 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
42291-0094-30 1 BOTTLE, SPRAY in 1 CARTON (42291-094-30) / 30 mL in 1 BOT... Azelastine Hydrochloride AvKARE 2021-03-03
47335-0779-91 1 BOTTLE, SPRAY in 1 BOX (47335-779-91) / 200 SPRAY, METERE... Azelastine Hydrochloride Sun Pharmaceutical Industries, Inc. 2012-05-24
50090-2330-00 1 BOTTLE, SPRAY in 1 CARTON (50090-2330-0) / 200 SPRAY, MET... Azelastine Hydrochloride A-S Medication Solutions 2016-03-15
50090-7461-00 1 BOTTLE, SPRAY in 1 CARTON (50090-7461-0) / 200 SPRAY, MET... AZELASTINE HYDROCHLORIDE A-S Medication Solutions 2024-11-19
59651-0214-30 1 BOTTLE, SPRAY in 1 CARTON (59651-214-30) / 200 SPRAY, MET... AZELASTINE HYDROCHLORIDE Aurobindo Pharma Limited 2020-05-08
60505-0833-05 1 BOTTLE, SPRAY in 1 CARTON (60505-0833-5) / 200 SPRAY, MET... Azelastine Hydrochloride Apotex Corp. 2010-03-01
65162-0676-84 1 BOTTLE, SPRAY in 1 CARTON (65162-676-84) / 30 mL in 1 BOT... Azelastine Hydrochloride Amneal Pharmaceuticals LLC 2017-09-05
67877-0477-50 1 SPRAY, METERED in 1 BOTTLE (67877-477-50) Azelastine Ascend Laboratories, LLC 2017-08-18
68788-4056-02 1 BOTTLE, SPRAY in 1 CARTON (68788-4056-2) / 200 SPRAY, MET... Azelastine Hydrochloride Preferred Pharmaceuticals Inc. 2025-11-17
68788-8514-02 1 BOTTLE, SPRAY in 1 CARTON (68788-8514-2) / 200 SPRAY, MET... AZELASTINE HYDROCHLORIDE Preferred Pharmaceuticals Inc. 2023-09-01
71205-0449-30 1 BOTTLE, SPRAY in 1 CARTON (71205-449-30) / 200 SPRAY, MET... Azelastine Hydrochloride Proficient Rx LP 2020-04-01
72603-0611-01 1 BOTTLE, SPRAY in 1 CARTON (72603-611-01) / 200 SPRAY, MET... AZELASTINE HYDROCHLORIDE NorthStar Rx LLC 2025-07-01
Observed labelers: A-S Medication Solutions (2) · Preferred Pharmaceuticals Inc. (2) · Amneal Pharmaceuticals LLC (1) · Apotex Corp. (1) · Ascend Laboratories, LLC (1) · Aurobindo Pharma Limited (1) · +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.